Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA centaur BNP assay

被引：45
|
作者：
Mueller, T
Gegenhuber, A
Poelz, W
Haltmayer, M
机构：
[1] Konventhosp Barmherzige Brueder, Dept Lab Med, A-4021 Linz, Austria
[2] Konventhosp Barmherzige Brueder, Dept Internal Med, A-4021 Linz, Austria
[3] Univ Linz, Dept Appl Syst Sci & Stat, A-4040 Linz, Austria
来源：
CLINICAL CHEMISTRY | 2004年 / 50卷 / 06期
关键词：
D O I：
10.1373/clinchem.2004.031484
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1104 / 1106
页数：3
相关论文
共 50 条
  • [1] Evaluation of the Advia Centaur BNP assay
    Hedberg, P
    Pikkujämsä, S
    Uusimaa, P
    Puukka, M
    CLINICA CHIMICA ACTA, 2005, 355 : S111 - S111
  • [2] Harmonization of the Bayer ADVIA Centaur and Abbott AxSYM automated B-type natriuretic peptide assay in patients on hemodialysis
    Barak, M
    Weinberger, R
    Marcusohn, J
    Froom, P
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (05) : 554 - 556
  • [3] Evaluation of a rapid automated immunoassay for B-type natriuretic peptide (BNP)-comparison with the Biosite Triage BNP assay.
    Oswal, H
    Inn, M
    Jarvinen, C
    Devaraj, S
    CLINICAL CHEMISTRY, 2005, 51 : A21 - A21
  • [4] Comparison of the Bayer ADVIA Centaur BNP assay with the Roche ELECSYS pro-BNP assay.
    Henley, R
    Van der Merwe, L
    Cockcroft, J
    Dunstan, FD
    John, R
    CLINICAL CHEMISTRY, 2003, 49 (06) : A34 - A34
  • [5] Circulating levels of B-type natriuretic peptide (BNP) are useful for diagnosis and are associated with severity of symptoms in chronic heart failure:: preliminary data from a multicenter study with Bayer ADVIA Centaur® BNP assay.
    Ghani, F
    Wu, A
    Bijou, R
    Haverstick, DM
    Feldkamp, CS
    Thiel, R
    Grant, A
    Ahnadi, C
    Mair, J
    Despres, N
    Mindicino, H
    Conarpe, C
    Packer, M
    CLINICAL CHEMISTRY, 2003, 49 (06) : A67 - A68
  • [6] Clinical assessment of the BNP Advia Centaur assay.
    Dorizzi, RM
    Meneghelli, S
    Cicoira, A
    Zanolla, L
    Lerose, N
    Rizzotti, P
    CLINICAL CHEMISTRY, 2004, 50 (06) : A18 - A18
  • [7] Evaluation of the analytical performance characteristics of the Bayer ACS:180® B-type natriuretic peptide (BNP) assay
    Wians, FH
    Wilson, BA
    Grant, A
    Bailey, J
    Gheorghiu, I
    Conarpe, C
    Mindicino, H
    Thakur, K
    Belenky, A
    Despres, N
    Bluestein, B
    CLINICA CHIMICA ACTA, 2005, 353 (1-2) : 147 - 155
  • [8] Analytical evaluation of B-type natriuretic peptide (BNP) on the ADVIA IMS® 800i system
    Ahnadi, C. E.
    Pomerleau, J. F.
    Levine, R.
    Tan, S.
    Grant, A.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A122 - A122
  • [9] Radioimmunometric assay of B-type natriuretic peptide (BNP) in heart transplantation:: correlation between BNP determinations and biopsy grading of rejection
    Hervás, I
    Almenar, L
    Pérez-Pastor, JL
    Chirivella, M
    Osa, A
    Martínez-Dolz, L
    Bello, P
    Martí, JF
    Arnau, MA
    Vera, F
    Rueda, J
    Palencia, M
    Mateo, A
    NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (08) : 925 - 931
  • [10] Analytical and clinical evaluation of the Bayer ADVIA centaur automated B-type natriuretic peptide assay in patients with heart failure: A multisite study
    Wu, AHB
    Packer, M
    Smith, A
    Bijou, R
    Fink, D
    Mair, J
    Wallentin, L
    Johnson, N
    Feldcamp, CS
    Haverstick, DM
    Ahnadi, CE
    Grant, A
    Despres, N
    Bluestein, B
    Ghani, F
    CLINICAL CHEMISTRY, 2004, 50 (05) : 867 - 873
12345